LETTER TO THE EDITOR
The health outcome and the costs of primary HPV testing with dual-stain cytology triage in cervical cancer screening
Submission date: 2018-08-04
Acceptance date: 2018-09-03
Publication date: 2018-11-20
Pol J Pathol 2018;69(3):319-320
TOPICS
REFERENCES (4)
1.
Celewicz A, Celewicz M, Wê¿owska M, et al. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer. Pol J Pathol 2018; 69: 42-47.
2.
Tjalma WAA. Diagnostic performance of dual-staining cytology for cervical cancer screening: A systematic literature review. Eur J Obstet Gynecol Reprod Biol 2017; 210: 275-280.
3.
Tjalma WAA, Kim E, Vandeweyer K. The impact on women’s health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium. Eur J Obstet Gynecol Reprod Biol 2017; 212: 171-181.
4.
Tjalma WA. The ideal cervical cancer screening recommendation for Belgium, an industrialized country in Europe. Eur J Gynaecol Oncol 2014; 35: 211-218.
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
